ArticleThe pharmacogenomics journal2017
Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin.
T F Spracklen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled itcites it